The immunological co-adjuvant action of liposomal interleukin-2: The role of mode of localisation of the cytokine and antigen in the vesicles

1998-01-01
In experiments designed to study the co-adjuvant action of interleukin-2, a model antigen (tetanus toroid) was passively entrapped in, or covalently coupled to multilamellar liposomes in the presence or absence of interleukin-2 (IL-2). When present, IL-2 was either co-entrapped with the toroid, entrapped alone in liposomes with toroid coupled to their surface, or coupled to the surface of liposomes with entrapped toroid. The role of spatial localization of IL-2 within the liposomal structure (vis a vis that of the toroid) was studied in terms of its immunoadjuvant action in vivo, Male CD-1 mice were injected intramuscularly twice with a variety of toxoid-containing liposomal preparations in the absence or presence of IL-2 incorporated in the same liposomes as above, In some experiments mice were immunized with liposomal toroid mixed with separately entrapped IL-2. Results show that IL-2 augments significantly secondary immune responses (IgG(1), IgG(a), IgG(2b) subclasses) against the liposomal toroid (up to 15-fold compared with the liposomal toroid alone), regardless of cytokine and antigen mode of accommodation in the liposomal structure but only when both are present in the same vesicles. It is suggested that liposomal IL-2 may prove useful as a co-adjuvant for vaccines which are weak or ineffective.
JOURNAL OF DRUG TARGETING

Suggestions

A NONIONIC SURFACTANT VESICLE-IN-WATER-IN-OIL (V/W/O) SYSTEM - POTENTIAL USES IN DRUG AND VACCINE DELIVERY
YOSHIOKA, T; SKALKO, N; Gürsel, Mayda; GREGORIADIS, G; FLORENCE, AT (Informa UK Limited, 1995-01-01)
An aqueous dispersion of niosomes (non-ionic surfactant vesicles) emulsified in an external oil phase forms the vesicle-in-water-in-oil (v/w/o) system described in this paper. The properties of the surfactant used to form the vesicles, the surfactant or surfactant mixture used to stabilize the emulsion and the nature of the oil phase can be changed to provide systems of different capacities for drug or antigen and different release characteristics. The same nonionic surfactant is used as the principle amphi...
Concentration-dependent differing actions of the nonsteroidal anti-inflammatory drug, celecoxib, in distearoyl phosphatidylcholine multilamellar vesicles
Sade, Asli; Banerjee, Sreeparna; Severcan, Feride (Informa UK Limited, 2010-06-01)
The interactions of the nonsteroidal anti-inflammatory drug, celecoxib, with 1,2-distearoyl-sn-glycero-3-phosphocholine multilamellar vesicles were studied as a function of temperature and different drug concentrations, using Fourier transform infrared spectroscopy, differential scanning calorimetry, and turbidity technique at 440 nm. Our studies reveal that celecoxib lowers the main phase-transition temperature and decreases the fluidity of the membranes at all concentrations. Celecoxib induced opposing ef...
A novel method to measure the glass and melting transitions of pharmaceutical powders
Abiad, Mohamad G.; Gonzalez, David C.; Mert, Behiç; Campanella, Osvaldo H.; Carvajal, M. Teresa (Elsevier BV, 2010-08-30)
A method to measure thermo-mechanical properties of pharmaceutical and polymeric powders was developed The measurements are conducted by characterizing the material's response to applied acoustic waves Measurements were performed using griseofulvin, felodipine and indomethacin as model drugs and polyethylene oxide (MW 200,000, 900,000, 2,000,000 Da) as model polymers. The method employed measures the mechanical Impedance enabled the calculation of the powder theological and thermo-mechanical properties. Mea...
Dual-adjuvant effect of pH-sensitive liposomes loaded with STING and TLR9 agonists regress tumor development by enhancing Th1 immune response
Kocabas, Banu Bayyurt; Almacioglu, Kubra; Bulut, Esin Alpdundar; Gucluler, Gozde; Tincer, Gizem; Bayik, Defne; Gürsel, Mayda; GÜRSEL, İHSAN (Elsevier BV, 2020-12-01)
Nucleic acid-based pattern recognition receptor agonists are effective adjuvants and immunotherapeutic agents. Rather than single applications, ligand combinations could synergistically potentiate immune responses by elevating cytokine and chemokine production via triggering multiple signaling pathways. However, short half-lives of such labile ligands due to nuclease attack and limited cellular uptake due to their structure significantly hamper their in vivo performances. More importantly, simultaneous deli...
Encapsulation of two different TLR ligands into liposomes confer protective immunity and prevent tumor development
Bayyurt, Banu; Tincer, Gizem; Almacioglu, Kubra; Alpdundar, Esin; Gürsel, Mayda; GÜRSEL, İHSAN (Elsevier BV, 2017-02-10)
Nucleic acid-based Toll-like receptor (TLR) ligands are promising adjuvants and immunotherapeutic agents. Combination of TLR ligands potentiates immune response by providing synergistic immune activity via triggering different signaling pathways and may impact antigen dependent T-cell immune memory. However, their short circulation time due to nuclease attack hampers their clinical performance. Liposomes offer inclusion of protein and nucleic acid-based drugs with high encapsulation efficiency and drug load...
Citation Formats
M. Gürsel, “The immunological co-adjuvant action of liposomal interleukin-2: The role of mode of localisation of the cytokine and antigen in the vesicles,” JOURNAL OF DRUG TARGETING, pp. 93–98, 1998, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/39193.